Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population
IRon overload screeNing tool (IRON): Development of a tool to guide screening in primary care
Renal impairment, hemoglobinuria, and hemoglobinemia among patients with idiopathic thrombocytopenic purpura
Systemic infections mimicking thrombotic thrombocytopenic purpura
Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population
Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease
High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: A retrospective investigation on 133 patients treated in a single institution
Follicular lymphoma: 2011 update on diagnosis and management
Dysplastic macropolycytes in myelodysplasia-related acute myeloid leukemia
Primary effusion lymphoma in a HIV-negative patient associated with hypogammaglobulinemia
Concurrent chronic lymphocytic leukemia and prolymphocytic leukemia derived from two separate B-cell clones
Blindness in a patient with chronic lymphocytic leukemia
Vinblastine in the treatment of children and adolescents with refractory immune thrombocytopenia
Sideroblastic anemia, iron overload, and ALAS2 R452S in African-American males: Phenotype and genotype features of five unrelated patients
Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant
Published guidelines versus real-life practice in the diagnosis and treatment of essential thrombocythemia
An evaluation of concurrent G6PD (A−) deficiency and sickle cell trait in Malian populations of children with severe or uncomplicated P. falciparum malaria
Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study
Clinical and laboratory features of leukemias at the time of diagnosis: An analysis of 1,004 consecutive patients
Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease
Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle-cell disease
Changing patterns of splenectomy in transfusion-dependent thalassemia patients
Chronic myeloid leukemia 2011: Successes, challenges, and strategies—Proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop
Myeloma ASH 2010 highlights
Erratum: Analysis of alpha hemoglobin stabilizing protein overexpression in murine β-thalassemia
Black Swans, Human Biology and Iron Metabolism - From Genes to Therapies
FBXL5 and Its Contributions to Iron Homeostasis
Mammalian Siderophore in Erythropoiesis
Chairs: Matthias Hentze, MD; Elizabeth A. Leibold, PhD
MITOFERRIN1 AND ATPIF1: REGULATORS OF MITOCHONDRIAL IRON AND HEME METABOLISM
WHY MULTI TARGET IRON CHELATORS AS NEUROPROTECTIVE-NEURORESTORATIVE DRUGS FOR NEURODEGENRATIVE DISORDERS
Clem Finch Lecture
A NEW MOUSE MODEL WITH GAIN OF IRP FUNCTION TO INVESTIGATE THE IN VIVO ROLE OF THE IRP/IRE SYSTEM
MECHANISM OF SENSING IRON BY PLANT TRANSCRIPTION FACTOR IDEF1
NCB5OR OXIDOREDUCTASE IS INVOLVED IN IRON METABOLISM
EXOGENOUSLY ADMINISTERED FERRITIN AND FERRI-TRANSFERRIN REGULATE LIVER HEPCIDIN EXPRESSION BY DISTINCT MECHANISMS
TARGETED DELETION OF THE MOUSE MITOFERRIN1 GENE: FROM ANEMIA TO PROTOPORPHYRIA
MECHANISMS OF IRON ENTRY AND CHELATION BY HUMAN FERROCHELATASE
CONSEQUENCES OF IRON REGULATORY PROTEIN 1 ACTIVATION IN MOUSE MODELS OF FRIEDREICH'S ATAXIA
MITOCHONDRIAL IRON STARVATION AFFECTS CYTOSOLIC IRON STORAGE COMPARTMENT: A HYPOTHETICAL PATHWAY
HEME EFFLUX FROM MITOCHONDRIA REQUIRED FOR HEME BIOSYNTHESIS IN THE YEAST SACCHAROMYCES CEREVISIAE
A NOVEL MITOCHONDRIAL ISOFORM OF THE HEME EXPORTER FLVCR1 INVOLVED IN HEME BIOSYNTHESIS
CONDITIONAL FERRITIN H DELETION REDUCES MATURE B LYMPHOCYTE POPULATION
FERROPORTIN EXPRESSION UNDERLIES DIFFERENCES IN THE HANDLING OF NON-TRANSFERRIN-BOUND IRON BY HUMAN T LYMPHOCYTES AND MONOCYTES
REGULATION OF HEPCIDIN BY MICROBIAL MOLECULES
AN UNEXPECTED EXTRA-HEPATOCYTIC FUNCTION OF HFE: MACROPHAGE-HFE IS CRITICAL FOR LIPOPOLYSACCHARIDE (LPS)-CONTROLLED HEPATIC HEPCIDIN ACTIVATION
IRON DEFICIENCY IS ASSOCIATED WITH A PRO-INFLAMMATORY CONDITION DUE TO HEPCIDIN SUPPRESSION
NITROGEN MONOXIDE (NO) STORAGE AND TRANSPORT IN CELLS IS MEDIATED BY GLUTATHIONE-S-TRANSFERASE π AND MRP1 VIA DINITROSYL IRON COMPLEXES
PREPARATION AND EVALUATION OF FLUORESCENT AND BIOTINYLATED HEPCIDIN ANALOGS AS HEPCIDIN AGONISTS
CHANGES IN PITUITARY IRON AND VOLUME IN TRANSFUSIONAL IRON OVERLOAD
DEVELOPMENT OF FERRITIN H- AND L-CHAIN OVEREXPRESSING NEURONAL, EMBRYONIC AND HEMATOPOIETIC STEM CELLS AS MR REPORTER
FATE OF MONODISPERSE SUPERPARAMAGNETIC IRON BASED NANOPARTICLES IN VIVO
ASSESSMENT OF IRON ACCUMULATION IN KIDNEYS OF SICKLE CELL DISEASE PATIENTS BY R2 MAGNETIC RESONANCE IMAGING
CARDIAC IRON AND FUNCTION BY MRI IN PATIENTS WITH FRIEDREICH ATAXIA, A PILOT STUDY
ION CHANNELS IN FERRITIN NANOCAGES: MOVING IRON AND NUCLEATING MINERALS
HEME PLAYS A KEY ROLE IN IRON RELEASE FROM THE BACTERIAL IRON STORAGE PROTEIN BACTERIOFERRITIN
THE UNIVERSAL PATHWAY OF IRON TRAFFIC IN FERRITIN
RELEASE OF STORED IRON FROM FERRITIN
RNA INTERFERENCE OF FERRITIN SUBUNIT GENES IN CLOCK NEURONS OF DROSOPHILA RESULTS IN LOSS OF CIRCADIAN RHYTHMS
CHARACTERIZATION OF MITOCHONDRIAL FERRITIN PROMOTER
SICKLE HEMOGLOBIN AFFORDS PROTECTION AGAINST FREE HEME AND CONFERS HOST TOLERANCE TO PLASMODIUM INFECTION
THE ROLE OF SIDEROCALINS IN ANTI-BACTERIAL IRON SEQUESTRATION AND ENDOGENOUS IRON TRANSPORT
HEPATITIS C VIRUS DISRUPTS BMP/SMAD SIGNALING SUPPRESSING HEPCIDIN
PROTOZOAN PATHOGEN LEISHMANIA DONOVANI DOWN-REGULATES FERROPORTIN IN HOST MACROPHAGES BY HEPCIDIN-INDEPENDENT MECHANISM TO PROMOTE ITS INTRACELLULAR SURVIVAL ADVANTAGE
A CENTRAL ROLE FOR FREE HEME IN THE PATHOGEN ESIS OF SEVERE SEPSIS
TMPRSS6, AN INHIBITOR OF HEPATIC BMP/SMAD SIGNALING, IS REQUIRED FOR HEPCIDIN SUPPRESSION AND IRON LOADING IN A MOUSE MODEL OF β-THALASSEMIA
A HIGH THROUGH-PUT SCREEN IDENTIFIES MCP-1 (CCL2) AS A NOVEL REGULATOR OF IRON HOMEOSTASIS AND A MODIFIER OF HEREDITARY HEMOCHROMATOSIS DISEASE SEVERITY
SURVIVAL AND MORBIDITY ASSOCIATED WITH SERUM FERRITIN >1000 μG/L IN HEMOCHROMATOSIS PROBANDS WITH HFE C282Y/C282Y IN A REFERRAL PRACTICE
NTBI AND THE PATHOPHYSIOLOGY OF IRON OVERLOAD
NON-TRANSFERRIN BOUND IRON TRANSPORT IN VIVO IS IRON REGULATED IN HEREDITARY HAEMOCHROMATOSIS
HFE C282Y HOMOZYGOSITY IS ASSOCIATED WITH AN INCREASED RISK OF TOTAL HIP REPLACEMENT FOR OSTEOARTHRITIS IN MEN BUT NOT WOMEN
TRAFFIC OF TRANSFERRIN-IRON INTO CYTOSOL AND MITOCHONDRIA IN K562 CELLS: ROLE OF DIHYDROBENZOATES AS PUTATIVE IRON CHAPERONS
ACTIVATION OF THE HIF PROLYL HYDROXYLASE 2 BY THE IRON CHAPERONE PCBP1
FAM96A AND FAM96B MUTUALLY EXCLUSIVELY ASSOCIATE WITH CIAO1 TO CONTROL MATURATION AND STABILITY OF IRP1 AND IRP2 IN HUMAN CELLS
INTESTINAL FERRITIN H IS REQUIRED FOR AN ACCURATE CONTROL OF IRON ABSORPTION
HEPCIDIN-INDEPENDENT INTERNALIZATION OF FERROPORTIN REVEALS AN EVOLUTIONARILY CONSERVED REGULATION OF IRON HOMEOSTASIS
IRP1 MUTANTS RESISTANT TO IRON INDUCED PROTEIN DEGRADATION
HEMOLYTIC ANEMIA TRIGGERS HEPCIDIN REPRESSION AND OVERRIDES THE IRON SIGNALLING IN UROPORPHYRINOGEN III SYNTHASE DEFICIENT MICE
GASTRIN-DEFICIENT MICE HAVE DISTURBED HAEMATOPOIESIS IN RESPONSE TO IRON DEFICIENCY
THE ROLE OF INTERLEUKIN-6 AND BONE-MARROW DERIVED CELL PRODUCTION OF HEPCIDIN IN ANEMIA OF INFLAMMATION
MUTATION OF THE GASTRIC HYDROGEN-POTASSIUM ATPASE ALPHA SUBUNIT CAUSES IRON-DEFICIENCY ANEMIA
MISSENSE SLC25A38 VARIATIONS PLAY AN IMPORTANT ROLE IN AUTOSOMAL RECESSIVE INHERITED SIDEROBLASTIC ANAEMIA
INTRAVENOUS IRON IN A MOUSE MODEL MIMICKING INTENSIVE CARE ANEMIA
BMPER IS A REGULATOR OF HEPCIDIN IN HEPATOCYTES AND IS UP-REGULATED IN CHRONIC ANAEMIA AND HYPOXIA
THE LIVER-SPECIFIC MICRORNA-122 CONTROLS SYSTEMIC IRON HOMEOSTASIS IN THE MOUSE
HEPCIDIN-MEDIATED INTERNALIZATION OF FERROPORTIN INDEPENDENT OF JAK2 ACTIVITY AND PHOSPHORYLATION OF FERROPORTIN TYROSINE RESIDUES 20, 302, 303 AND 538
HEPCIDIN-INDUCED UBIQUITINATION IS REQUIRED FOR FERROPORTIN INTERNALIZATION
MACROPHAGES MODULATE IRON AVAILABILITY AND ERYTHROID DEVELOPMENT IN B-THALASSEMIA INTERMEDIA
DIFFERENTIAL CONTRIBUTION OF HEPATOCYTES AND MACROPHAGES IN HEME DETOXIFICATION DURING INTRAVASCULAR HEMOLYSIS
DELINEATING THE MECHANISM OF HRG-1-MEDIATED HEME TRANSPORT IN BONE MARROW DERIVED MACROPHAGES
STUDIES ON HEME OXYGENASE 1 DURING ERYTHROID DIFFERENTIATION
A NOVEL DISEASE ENTITY CHARACTERIZED BY HEMOPHAGOCYTIC SYNDROME CAUSED BY DEFECTIVE HEME OXYGENASE (HO)-1 WITH LOSS OF NORMAL ACTIVITY AND GAIN OF PEROXIDASE FUNCTION
ROLE OF HEMOPEXIN IN DUODENAL INORGANIC AND HEME IRON ABSORPTION
IRON INSUFFICIENCY COMPROMISES MOTOR NEURONS AND THEIR MITOCHONDRIAL FUNCTION IN IRP-NULL MICE
A NOVEL RELATIONSHIP BETWEEN β-AMYLOID PROTEIN PRECURSOR AND TAU IN ALZHEIMER'S DISEASE RELATED IRON DISRUPTION
RETINAL PIGMENT EPITHELIUM-SPECIFIC KNOCKOUT OF THE FERROXIDASE HEPHAESTIN RESULTS IN IRON ACCUMULATION AND DEGENERATION
CHARACTERIZATION OF MICE EXPRESSING THE PATHOGENIC L FERRITIN MUTANT (FTL-498INSTC) CAUSING HEREDITARY FERRITINOPATHY
IRON DEFICIENCY UP-REGULATES DOPAMINE-RELATED GENES IN THE VENTRAL MIDBRAIN IN INBRED MICE
INVESTIGATING THE MECHANISM AND PATHOPHYSIOLOGY OF ISCU MYOPATHY
HFE DISRUPTION IN MICE SENSITIZES THE LIVER TO HIGH FAT DIET-INDUCED LIPOTOXICITY VIA INTRAHEPATIC HYPOXIA AND IMPAIRED LIPID METABOLISM
UPREGULATION OF GENES INVOLVED IN CHOLESTEROL SORTING IN THE FACE OF HEPATIC IRON LOADING
RELATIONSHIP OF HFE MUTATIONS, HEPATIC IRON DEPOSITION AND HISTOLOGIC FEATURES IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: RESULTS FROM THE NASH CRN
INTEREST OF FUNCTIONAL IN VITRO STUDIES FOR EVALUATING THE GENOTYPE-PHENOTYPE CORRELATIONS IN FERROPORTIN DISEASE
GLOBAL GENE EXPRESSION ANALYSIS OF HUMAN ERYTHROID PROGENITORS
PERICENTRIOLAR IRON TRAFFICKING DURING HUMAN ERYTHROPOIESIS
HEPCIDIN REGULATES FERROPORTIN EXPRESSION AND INTRACELLULAR IRON CONCENTRATION OF ERYTHROBLASTS
TRANSFERRIN RECEPTOR 2 IS A COMPONENT OF THE ERYTHROPOIETIN RECEPTOR COMPLEX AND IS REQUIRED FOR EFFICIENT ERYTHROPOIESIS
APO-TRANSFERRIN INJECTIONS REDUCE TRANSFERRIN RECEPTOR 1 CONCENTRATION ON ERYTHROID PRECURSORS AND REVERSE INEFFECTIVE ERYTHROPOIESIS IN SPLENECTOMIZED BETA-THALASSEMIC MICE
EXAMINATION OF POTENTIAL FACTORS INVOLVED IN THE REGULATION OF HEPCIDIN IN β-THALASSEMIA
RENAL HANDLING OF IRON IN MOUSE MODELS OF IRON OVERLOAD: RECENT CONCEPT
MOUSE MODELS FOR FERROPORTIN FUNCTION WITH IMPAIRED HEPCIDIN REGULATION
IRON OVERLOAD RESULTING FROM INCREASED INTESTINAL DMT1 EXPRESSION
DUODENAL HYPOXIA INDUCIBLE FACTOR 2 (HIF-2) CONTRIBUTES TO IRON ACCUMULATION IN A GENETIC MOUSE MODEL OF HEMOCHROMATOSIS
SUPPRESSION OF HEMOJUVELIN EXPRESSION IN THE ZEBRAFISH RESULTS IN IRON OVERLOAD AND CARDIOPATHY
ENHANCED LIVER BMP/SMAD SIGNALING BUT DECREASED HEPCIDIN EXPRESSION IN TRANSGENIC MICE UBIQUITOUSLY OVEREXPRESSING HFE
SERUM HEPCIDIN BY A MASS-SPECTROMETRY BASED ASSAY AT POPULATION LEVEL RESULTS FROM THE VAL BORBERA STUDY
THE SERUM HEPCIDIN-TO-FERRITIN RATIO IS AN ACCURATE PREDICTOR OF INCREASED HEPATIC IRON AND LIVER CIRRHOSIS IN NON-HEMOCHROMATOSIS SUBJECTS
GENETIC MODIFIERS IN HFE-HEMOCHROMATOSIS: ANALYSIS OF 355 TAG SNPS IN AN ITALIAN POPULATION OF C282Y HOMOZYGOTES
URINARY HEPCIDIN IS A PROMISING BIOMARKER OF SEVERITY OF ACUTE KIDNEY INJURY FOLLOWING CARDIOPULMONARY BYPASS SURGERY
REMODELING OF GLUCOSE AND IRON METABOLISMS IN FUMARATE HYDRATASE-DEFICIENT RENAL CELL CARCINOMA: AN EXTENSION OF THE WARBURG EFFECT
A NOVEL IRON FACILITATOR LS081 INHIBITS HIF-1α PROTEIN EXPRESSION AND FUNCTIONS AS AN ANTICANCER AGENT
NOX-H94, IN VITRO AND IN VIVO CHARACTERIZATION OF A HEPCIDIN BLOCKING SPIEGELMER®
EXPLOITING LIPOCALIN BIOCHEMISTRY FOR THE TREATMENT OF ANEMIA: DISCOVERY AND CHARACTERIZATION OF AN ANTI-HEPCIDIN THERAPEUTIC
THE RATIONAL DESIGN OF MINI-HEPCIDINS FOR THE TREATMENT OF IRON OVERLOAD
PHARMACOLOGIC DOWNREGULATION OF HEPCIDIN REVERSES ANEMIA OF CHRONIC DISEASE
THE SMALL MOLECULE DMT1 INHIBITOR XEN601 BLOCKS IRON UPTAKE IN RODENT MODELS OF NON-HEME IRON HYPERABSORPTION
RED BLOOD CELL PRECURSORS FROM SICKLE CELL PATIENTS RESPOND TO FERRITIN HEAVY CHAIN AND ABSCISSIC ACID AS THERAPEUTIC AGENTS FOR MALARIA, SICKLE CELL DISEASE, AND BETA-THALASSEMIA
HEPATIC IRON ACCUMULATION ATTENUATES HEPCIDIN EXPRESSION
TRANSCRIPTIONAL SUPPRESSION OF HEPCIDIN BY GROWTH FACTORS
LIVER SPECIFIC DELETION OF ALK2 (ACVR1) OR ALK3 (BMPR1A) INDUCES HEPCIDIN DEFICIENCY AND IRON-OVERLOAD IN MICE
MOUSE LIVER HEMOJUVELIN PROTEIN LEVELS DO NOT CHANGE IN IRON DEFICIENCY OR IRON OVERLOAD
FUNCTIONAL STUDIES OF MT2 MUTATIONS FOUND IN IRIDA PATIENTS: NEW INSIGHTS INTO THE REGULATION OF HEPCIDIN EXPRESSION
THE RS855791 TMPRSS6 COMMON VARIANT MODULATES HEPCIDIN PROMOTER IN VITRO AND IS ASSOCIATED WITH LOW SERUM HEPCIDIN/FERRITIN RATIO IN NORMAL INDIVIDUALS
HEPATIC IRON LOADING SUPPRESSES OXIDATIVE STRESS RESPONSE MECHANISMS IN ATM−/− MOUSE LIVER
GENETIC AND BIOCHEMICAL ANALYSIS OF HIGH IRON TOXICITY IN YEAST
UNDERSTANDING THE ROLE OF NRF2/ARE SIGNALLING IN THE CELLULAR DEFENCE AGAINST IRON TOXICITY
MOVED TO POSTER #28
LABILE PLASMA IRON DOES NOT CORRELATE WITH BLOOD AND PLASMA MARKERS OF OXIDATIVE STRESS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
ALTERED PARAOXONASE EXPRESSION IN PATIENTS WITH GENETIC HAEMOCHROMATOSIS
METAL INTERACTIONS IN DROSOPHILA
TRANSCRIPTIONAL REGULATION OF THE MENKES COPPER ATPASE (ATP7A) GENE BY HYPOXIA INDUCIBLE FACTOR (HIF2α) IN INTESTINAL EPITHELIAL CELLS
REGULATION OF DCYTB BY CELLULAR COPPER STATUS IS MEDIATED BY HYPOXIA INDUCIBLE FACTOR 2α (HIF-2α) IN THE DUODENUM
STUDIES ON THE INTERACTION OF CERULOPLASMIN WITH PROTEINS OF IRON METABOLISM
THE EFFECT OF COPPER LOADING AND DEFICIENCY ON IRON ABSORPTION IN CACO-2 CELLS
A NOVEL TARGETING STRATEGY FOR THE DESIGN OF NEW CHEMOTHERAPEUTICS: ACTIVATING THE LYSOSOMAL APOPTOTIC PATHWAY VIA CHELATORS
INVESTIGATING FBXL5'S PHYSIOLOGICAL CONTRIBUTION TO THE MAINTANANCE OF IRON HOMEOSTASIS
THE POTENTIAL ROLE OF THE HEPATIC STELLATE CELL IN IRON HOMEOSTASIS
IN SILICO ANALYSES OF PROMOTER REGULATORY TARGETS IN THE IRON METABOLISM PATHWAY
CELLULAR IRON-DEPLETION STIMULATES THE JNK AND P38 MAP SIGNALING TRANSDUCTION PATHWAYS VIA DISSOCIATION OF ASK1-THIOREDOXIN AND ACTIVATION OF ASK1
THE PROTEASOME INHIBITOR BORTEZOMIB AFFECTS TFR1 AND FTH EXPRESSION INDEPENDENTLY OF IRE/IRP-MACHINERY IN MULTIPLE MYELOMA CELL LINES
ROLE OF MITOCHONDRIAL ATP-BINDING CASSETTE PROTEIN-1 IN MITOCHONDRIAL IRON HOMEOSTASIS AND CYTOSOLIC IRON-SULFUR PROTEIN MATURATION
MITOFERRIN IS ESSENTIAL FOR SPEMATOGENESIS IN DROSOPHILA MELANOGASTER
HUMAN FERREDOXIN 2, AND NOT ADRENODOXIN/FERREDOXIN 1, IS REQUIRED FOR IRON-SULFUR CLUSTER PROTEIN BIOGENESIS AND PROPER CELLULAR IRON HOMEOSTASIS
CRUCIAL ROLE OF RICE MITOCHONDRIAL IRON TRANSPORTER, MIT, IN PLANT GROWTH
MOVED TO PODIUM #7
IRON-INDUCED MITOCHONDRIAL FAILURE AND STRATEGIES FOR CELLULAR PROTECTION IN PRIMARY NEURONS AND ASTROCYTES
AN ABNORMAL IRON METABOLISM IN INTERFERON TREATMENT
IRP1 OUTCOMPETES IRP2 FOR REGULATING CELLULAR IRON HOMEOSTASIS IN RESPONSE TO NITRIC OXIDE
HEPCIDIN REGULATION BY INNATE IMMUNE STIMULI
LEISHMANIA INFANTUM INFECTION MODULATES THE EXPRESSION OF DIFFERENT MACROPHAGE IRON METABOLISM PROTEINS
THE EVOLUTION OF SLC11 GENES IN VERTEBRATES: LESSONS FROM FISH
HEPCIDIN INDUCED HYPOFERRAEMIA IS ASSOCIATED WITH VIRAL SUPPRESSION UPON COMBINATION TREATMENT FOR HEPATITIS C
IRON HOMEOSTASIS IN WHOLE BODY AND INTESTINE-SPECIFIC HEPHAESTIN KNOCKOUT MICE
WITHDRAWN
DUODENAL PROTEINS INVOLVED IN IRON ABSORPTION ARE UP-REGULATED IN PATIENTS WITH ULCERATIVE COLITIS
ROLE OF TOLL-LIKE RECEPTORS AND MYD88 ADAPTOR PROTEIN SIGNALING IN INFLAMMATION-ASSOCIATED HYPOFERREMIA
MHC CLASS I ANTIGEN PRESENTATION: EFFECT OF HFE, A PROTEIN INVOLVED IN IRON METABOLISM
EFFECT OF INFLAMMATION ON PROTEINS INVOLVED IN IRON UPTAKE IN THE MOUSE DUODENUM: A TIME COURSE STUDY
IRON IN IMMUNE CELL DIFFERENTIATION AND ACTIVATION
DOWN-REGULATION OF FERROPORTIN BY INFLAMMATION IN HEPATOCYTES, MACROPHAGES AND DUODENAL CELLS OF BMP6 KNOCKOUT MICE
THE FERROXIDASE β-AMYLOID PROTEIN PRECURSOR FORMS A STABLE COMPLEX WITH LACTOFERRIN
BLUNTED HEPCIDIN RESPONSE TO INFLAMMATION IN THE ABSENCE OF HFE AND TFR2
NAILING DOWN THE CALCIUM-SENSITIVE LIGAND BINDING SITE IN THE HEMOGLOBIN SCAVENGER RECEPTOR CD163
STATINS PRIME-BOOST THE ACUTE PHASE RESPONSE THROUGH IL-6/C-EBP SIGNALING
ROLE OF FERRITIN RECEPTORS IN FERRITIN-INDUCED PROINFLAMMATORY SIGNALLING IN RAT HEPATIC STELLATE CELLS
MAPPING IRON IN HUMAN HEART TISSUE WITH MRI AND SYNCHROTRON X-RAY FLUORESCENCE MICROSCOPY
OPTIMIZING IRON CHELATOR TREATMENT IN SECONDARY SIDEROSIS EFFICACY OF DIVIDED DEFERASIROX (EXJADE) - DOSES
ANALYSIS OF BINDING SITE RESIDUES IN A NOVEL FELINE SERUM FERRITIN-BINDING PROTEIN
PROTEIN ASSOCIATION AND DISSOCIATION REGULATED BY EXTENSION PEPTIDE: A MODE FOR IRON CONTROL BY PHYTOFERRITIN
PRELIMINARY STUDY OF THE FERRITIN, HEAVY POLYPEPTIDE-LIKE 17 (FTHL17) GENE PRODUCT, A FERRITIN-LIKE PEPTIDE EXPRESSED IN SPERMATOGONIA AND IN EMBRYONIC CELLS
THE FERROXIDASE CENTER FACILITATES IRON LOADING INTO FERRITIN IN THE PRESENCE OF PHOSPHATE
HEPATIC IRON OVERLOAD IS A COMMON FEATURE OF CHRONIC HEPATITIS B AND IS MORE FREQUENT AND SEVERE IN PRESENCE OF COINFECTION WITH HEPATITIS D VIRUS
FERRITIN H CHAIN AFFORDS TOLERANCE TO MALARIA IN MICE
WITHDRAWN
A NOVEL POST-TRANSCRIPTIONAL REGULATION OF MULTICOPPER OXIDASE IN PROTOZOAN PARASITE LEISHMANIA DONOVANI IN RESPONSE TO IRON CHELATION
PHARMACOLOGICAL MODIFICATION OF IRON HOMEOSTASIS BY NIFEDIPINE AFFECTS THE COURSE OF SALMONELLA TYPHIMURIUM INFECTION
MOVED TO PODIUM #34
WITHDRAWN
WITHDRAWN
DIETARY IRON OVERLOAD INDUCES VISCERAL ADIPOSE TISSUE INSULIN RESISTANCE ASSOCIATED WITH HYPER-RESISTINEMIA, AND SYNERGIZES WITH OBESITY IN INDUCING SYSTEMIC INSULIN RESISTANCE
A COMPARISON OF SELF-REPORTED AND RECORD-LINKED BLOOD DONATION HISTORY IN AN AUSTRALIAN COHORT
PROGRESSIVE GLUTATHIONE DEPLETION REGULATES CERULOPLASMIN BY DUAL BUT OPPOSITE MECHANISM: IMPLICATION IN HEPATIC IRON OVERLOAD
RELIABLE QUANTIFICATION OF NON-TRANSFERRIN-BOUND IRON (NTBI) IN HEALTHY VOLUNTEERS BY IMPROVED HIGH SENSITIVE METHOD USING HPLC
CORRELATION OF IRON PARAMETERS WITH IRON REGULATORY GENE EXPRESSION IN PATIENTS PRESENTING WITH IRON OVERLOAD
A NOVEL N491S MUTATION IN HUMAN DMT1 GENE IMPAIRS PROTEIN TRAFFICKING AND LEADS, IN ASSOCIATION WITH G212V MUTATION, TO MICROCYTIC ANEMIA AND LIVER IRON OVERLOAD
EFFECT OF DIETARY IRON DEFICIENCY AND OVERLOAD ON ZIP14 AND DMT1 LEVELS IN RAT LIVER, PANCREAS, AND HEART
HFE C282Y HOMOZYGOTES BUT NOT OTHER HFE GENOTYPES SHOW RAPID SERUM FERRITIN ACCUMMULATION AFTER MENOPAUSE IN AN HFE-STRATIFIED COMMUNITY SAMPLE OF AUSTRALIAN WOMEN
TOTAL MORTALITY BY TRANSFERRIN SATURATION LEVELS: TWO GENERAL POPULATION STUDIES AND A META-ANALYSIS
HYPERFERRITINEMIA AND IRON DEFICIENCY IN A PATIENT WITH A NOVEL MUTATION IN THE TFR2 GENE, ANOTHER IN THE FTL GENE, AND METABOLIC SYNDROME: FAMILY STUDY
DIGENIC INHERITANCE OF MUTATIONS IN HFE AND TRF2 IN A SPANISH PATIENT WITH HEMOCHROMATOSIS
EFFECT OF AMBIGUOUS HEMOCHROMATOSIS GENE TEST RESULTS ON PHYSICIAN UTILIZATION
INITIAL SERUM FERRITIN LEVEL AS A PREDICTOR OF SURVIVAL IN
EVIDENCE OF SYNERGY WHEN DEFERASIROX AND DEFEROXAMINE ARE USED IN COMBINATION
MANAGEMENT, COSTS OF PHLEBOTOMIES AND USE OF REMOVED BLOOD IN HAEMOCHROMATOSIS VARIES THROUGHOUT EUROPE
EUROPEAN FEDERATION OF ASSOCIATIONS OF PATIENTS WITH HAEMOCHROMATOSIS (EFAPH): A BRIDGE BETWEEN PATIENTS AND RESEARCHERS
JUVENILE HEMOCHROMATOSIS DUE TO NOVEL MUTATIONS OF THE TFR2 GENE, REVEALED IN A YOUNG WOMAN AFTER PREGNANCY
DIABETES MIGHT BE FOLLOWED BY FATAL CARDIAC DYSFUNCTION IN JAPANESE PATIENTS WITH IRON OVERLOAD SYNDROMES
CARDIAC, PANCREATIC, AND HEPATIC IRON STORES IN HEREDITARY HEMOCHROMATOSIS
HEMOCHROMATOSIS-ASSOCIATED CHROMOSOME 6P HAPLOTYPES AND BLOOD CD8+ T-LYMPHOCYTE NUMBERS: A STUDY OF TWO GEOGRAPHICALLY DISTINCT POPULATIONS FROM PORTO AND ALABAMA
RELATIONSHIPS BETWEEN HLA-TYPE, T-LYMPHOCYTE SUBSETS, MHC-I LINKED HAPLOTYPES AND THE EXPRESSION OF IRON OVERLOAD IN C282Y HOMOZYGOUS INDIVIDUALS FOUND BY POPULATION SCREENING
ORIGIN OF CHELATABLE IRON DURING DEFERIPRONE AND COMBINATION THERAPIES: INSIGHTS FROM PLASMA NTBI AND LPI
BIVARIATE MIXTURE MODELS FOR THE JOINT DISTRIBUTION OF REPEATED SERUM FERRITIN AND TRANSFERRIN SATURATION MEASURES 12 YEARS APART IN A HEALTHY MIDDLE-AGED AUSTRALIAN POPULATION
MULTIETHNIC ASSOCIATIONS BETWEEN IRON STATUS MEASURES AND SINGLE NUCLEOTIDE POLYMORPHISMS IN IRON-RELATED GENES
GENETIC AND BIOCHEMICAL ANALYSES SUGGEST IRON CHAPERONE FUNCTION FOR PCBP2, PCBP3, AND PCBP4
THE IRON STATUS OF ENDOSOMES GOVERNS THE EFFICACY OF ENDOSOME-MEDIATED IRON DELIVERY TO MITOCHONDRIA
PHOSPHATE INHIBITS FE3+ BINDING BY TRANSFERRIN
INTESTINAL BRUSH-BORDER NA+/H+ EXCHANGERS ARE REQUIRED FOR IRON HOMEOSTASIS IN THE MOUSE
FUNCTIONAL EXPRESSION IN XENOPUS OOCYTES REVEALS THAT HUMAN FERROPORTIN IS AN IRON EXPORTER SHARED WITH ZINC
WITHDRAWN
WITHDRAWN
BIOCHEMICAL CHARACTERIZATION OF HUMAN POLY(C)-BINDING PROTEINS: FUNCTIONAL RELATIONSHIP BETWEEN NUCLEOTIDE AND METAL BINDING ACTIVITY
ON THE ORIGIN OF SERUM FERRITIN: SECRETED FERRITIN ARISES FROM THE DECOUPLING OF FERRITIN SYNTHESIS FROM FREE CYTOSOLIC IRON
TRANSFERRIN RECEPTOR TRAFFICKING AND DEGRADATION THROUGH A NOVEL LIPID RAFT PATHWAY INDUCED BY THE SMALL MOLECULE INHIBITOR NSC8679
WITHDRAWN
IDENTIFICATION OF AN ARABIDOPSIS MITOFERRIN-LIKE CARRIER PROTEIN INVOLVED IN CHLOROPLAST IRON METABOLISM
CONTRIBUTORS TO DIVALENT METAL TRANSPORTER (DMT1) TURNOVER
MUTAGENESIS OF THE IRON CHAPERONE PCBP1 SHOWS FUNCTIONALLY IMPORTANT SITES LOCALIZE IN THE NUCLEOTIDE-BINDING DOMAINS
DCYTB IS THE PRINCIPLE IRON-REGULATED FERRIC REDUCTASE PRESENT IN THE DUODENAL MUCOSA, AND IT IS NECESSARY FOR OPTIMAL IRON METABOLISM
MUTATIONAL ANALYSIS OF THE TRANSMEMBRANE PROTEIN ZIP14 REVEALS RESIDUES REQUIRED FOR IRON TRANSPORT
PHYTOSIDEROPHORE EFFLUX TRANSPORTERS ARE CRUCIAL FOR IRON ACQUISITION IN GRAMINACEOUS PLANTS
THE DIVINE SECRETS OF THE TRANSFERRIN/TRANSFERRIN RECEPTOR INTERACTION REVEALED
CRYSTAL STRUCTURE OF HUMAN SERUM TRANSFERRIN WITH IRON ONLY IN THE N-LOBE BOUND TO THE SOLUBLE PORTION OF THE HUMAN TRANSFERRIN RECEPTOR
MODULATION OF FERRIC (FE3+) REDUCTION BY DCYTB, ASCORBATE AND HIF 2-a IN CULTURED CELLS
IRP1−/− MICE EXHIBIT DEFECTS IN GLUCOSE METABOLISM AND ERYTHROPOIESIS
PFN2 AS A NOVEL IRP-TARGET MRNA
ROLES FOR IRP DEPENDENT AND INDEPENDENT MECHANISMS IN CONTROLLING FERRITIN EXPRESSION
SIRES: A WEB-SERVER TOOL FOR SEARCHING OF IRON-RESPONSIVE ELEMENTS
UNDERSTANDING THE HIERARCHICAL TRANSLATIONAL REGULATION ORCHESTRATED BY IRP
PREVALENCE AND PATHOGENESIS OF ANEMIA IN TUBERCULOSIS INFECTION
THE EFFECTS OF B16-F10 TUMOR CELL PROGRESSION ON IRON BIOMARKERS AND ANEMIA OF INFLAMMATION IN VIVO
HEPCIDIN LEVELS AND THEIR DETERMINANTS IN DIFFERENT TYPES OF MYELODYSPLASTIC SYNDROMES
ONE NOVEL MUTATION IN TMPRSS6 GENE IS RESPONSIBLE OF IRON REFRACTORY IRON DEFICIENT ANEMIA (IRIDA)
IDENTIFICATION OF TWO NOVEL PBGD MUTATIONS IN CHINESE PATIENTS WITH SYMPTOMS OF ACUTE PORPHYRIA ACCOMPANYING SEVERE ANEMIA
TRANSFERRIN GENE POLYMORPHISM RS3811647 AND IRON STATUS IN PATIENTS WITH IRON DEFICIENCY AND CONTROL SUBJECTS
TRANSFERRIN IS A MAJOR DETERMINANT OF HEPCIDIN EXPRESSION IN HYPOTRANSFERRINEMIC MICE
IRON-DEPENDENT REGULATION OF HEPATIC HEPCIDIN EXPRESSION IN HJV−/− MICE
PRODUCTION MECHANISM OF HEPCIDIN ISOFORMS, HEPCIDIN-20 AND HEPCIDIN-22
GUT-LIVER LINKAGE OF IRON METABOLISM IN NON-ALCOHOLIC FATTY LIVER DISEASES; ROLE OF INTESTINAL BMP-6 IN OBESE OB/OB MOUSE MODEL
INTRAPERITONEAL ADMINISTRATION OF HEPCIDIN IN 48-HOUR INTERVALS DOES NOT PREVENT HEPATIC IRON OVERLOAD IN MICE
THE METABOLIC FATE OF THE PEPTIDE HORMONE HEPCIDIN
PATHWAYS FOR THE REGULATION OF HEPCIDIN EXPRESSION IN ANEMIA OF CHRONIC DISEASE AND IRON DEFICIENCY ANEMIA IN VIVO
TMPRSS6 INDUCTION BY BMP6: A NEGATIVE FEEDBACK LOOP OF HEPCIDIN REGULATION
GENOME-WIDE SIRNA SCREEN IDENTIFIES NOVEL REGULATORS OF HEPCIDIN EXPRESSION AND IMPLICATES BMP/SMAD SIGNALLING AS AN INTEGRATIVE PATHWAY TOWARDS THE HEPCIDIN PROMOTER
BMP6 AND HEMOJUVELIN MEDIATED SIGNALING OF HEPCIDIN EXPRESSION DOES NOT REQUIRE NEOGENIN
BINDING KINETICS BETWEEN HEMOJUVELIN (HJV) AND BONE MORPHOGENETIC PROTEINS (BMPS) USING SURFACE PLASMON RESONANCE DEMONSTRATES SELECTIVE BINDING AFFINITY OF HJV FOR BMP LIGANDS
SUPPRESSION OF HEPATIC HEPCIDIN EXPRESSION IN RESPONSE TO ACUTE IRON DEPRIVATION IS ASSOCIATED WITH AN INCREASE OF MATRIPTASE-2 PROTEIN
GENISTEIN INCREASES STAT3 BINDING TO THE HEPCIDIN PROMOTER IN HUMAN HEPATOCYTES
SKELETAL MUSCLE HEMOJUVELIN IS DISPENSABLE FOR SYSTEMIC IRON HOMEOSTASIS
CHARACTERIZATION OF HUMAN FERROPORTIN EXPRESSION, CELLULAR LOCALIZATION AND RESPONSE TO HEPCIDIN USING MONOCLONAL ANTI-FERROPORTIN ANTIBODIES AND A FLUORESCENT HEPCIDIN ANALOG
MODULATION OF HEPCIDIN PRODUCTION DURING HIGH ALTITUDE-INDUCED HYPOXIA IN HUMANS IN VIVO
EFFECTS OF HYPOXIA ON IRON METABOLISM IN MACROPHAGES
COMPARATIVE EVALUATION OF NEPHROTOXICITY AND MANAGEMENT BY MACROPHAGES OF FOUR PHARMACEUTICAL IRON FORMULATIONS
IN VIVO BRAIN IRON MAPPING ON A PATIENT WITH ACERULOPLASMINEMIA COMPARED WITH HEALTHY SUBJECTS
FUNCTIONAL ROLE OF PRION PROTEIN IN IRON METABOLISM: PHYSIOLOGICAL AND PATHOLOGICAL IMPLICATIONS FOR PRION DISORDERS
HEPCIDIN CROSSES THE BLOOD-BRAIN BARRIER IN SYSTEMIC INFLAMMATION, AFTER MECHANICAL INJURY AND PARTICIPATES IN GLIAL SCAR FORMATION AND REGENERATION
AGE-RELATED CHANGES IN THE NIGROSTRIATAL SYSTEM IN H-FERRITIN-DEFICIENT MICE
IMPACT OF GENETIC VARIATION IN IRON TRANSPORT PATHWAYS ON NEUROPATHY MORBIDITY DURING ANTIRETROVIRAL THERAPY: RESULTS FROM THE CNS HIV ANTIRETROVIRAL THERAPY EFFECTS RESEARCH (CHARTER) GENOME-WIDE STUDY
APPLICATION OF IRON CHELATORS FOR THE TREATMENT OF NEURO-DEGENERATIVE DISEASES
RETINAL IRON REGULATION BY BMP6 AND HEPC: IMPLICATIONS FOR RETINAL NEURODEGENERATION
MECHANISMS OF NEUROPROTECTION BY HEMOPEXIN VIA CONTROL OF IRON HOMEOSTASIS IN BRAIN NEURONS
PANK2 SILENCING CAUSES GENERAL CELL GROWTH REDUCTION AND A CELL SPECIFIC FERROPORTIN UPREGULATION
ONE YEAR PRELIMINARY DATA FROM THE NON PROFIT PILOT STUDY: IRON-CHELATING TREATMENT IN PATIENTS WITH "NEURODEGENERATION WITH BRAIN IRON ACCUMULATION" (NBIA)
A RAPID MOLECULAR ANALYSIS IS EFFECTIVE TO QUICKLY DETERMINE FRATAXIN TRANSCRIPTIONAL AND PROTEIC LEVELS
PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION FIBROBLASTS DEFECTIVELY MODULATE FERRITINS AND TFR1 AFTER MILD/LONG IRON SUPPLEMENTATION
MATERNAL IRON STATUS IS A CRITICAL MODULATOR OF NEUROTOXICITY AND LEARNING OUTCOMES IN A RAT MODEL OF FETAL ALCOHOL SYNDROME
ACERULOPLASMINEMIA: REMOVAL OF EXCESS IRON FROM ORGANS BUT NOT THE BRAIN. A CASE REVIEW
IRON PLAYS A ROLE IN AXON GROWTH
WITHDRAWN
GENE EXPRESSION STUDIES IN FOUR DIFFERENT MOUSE MODELS SUPPORT THE CASE FOR BRAIN PERTURBATIONS IN IRON OVERLOAD DISORDERS
GENE EXPRESSION CHANGES RELATING TO KEY BRAIN FUNCTIONS AND NEUROPSYCHIATRIC DISORDERS IN THE TFR2 MUTANT MOUSE
CHARACTERIZATION OF THE IRON TRANSPORTER DMT1 IN HIPPOCAMPAL NEURONS
THE H63D HFE GENE VARIANT REDUCES SURVIVAL AND DISEASE DURATION IN TRANSGENIC MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS (SODG93A)
THE IRON STATUS OF ASTROCYTES AND CSF INFLUENCES IRON RELEASE FROM BRAIN ENDOTHELIAL CELLS IN BBB MODEL
IRON AND THE BIOGENESIS OF MELANIN AND MELANOSOMES IN THE RETINA
MOLECULAR CHANGES RELEVANT TO MOTOR NEURON DISEASE IN THE HFE−/− MOUSE MODEL OF HEMOCHROMATOSIS
ROOM TEMPERATURE SUSCEPTOMETRY FOR HEPATIC IRON MEASUREMENT
FLOW CYTOMETRY-BASED MEASUREMENT OF NON-TRANSFERRIN-BOUND IRON
HIGH SENSITIVITY DETECTION OF PLASMODIUM FALCIPARUM GAMETOCYTES USING HIGH FIELD GRADIENT MAGNETIC FRACTIONATION
SERUM HEPCIDIN ROUND ROBIN-2: TOWARDS A HARMONIZED ASSAY
SERUM HEPCIDIN RANGES AND BIOCHEMICAL CORRELATES IN A REFERENCE POPULATION
WITHDRAWN
MODIFIERS OF EXPRESSION OF HEMOCHROMATOSIS: LOOKING FOR NEW MARKERS OF DISEASE PROGNOSIS
THE EFFECT OF DEFERASIROX ON THE SPECTROPHOTOMETRIC ASSAYS FOR SERUM IRON AND SERUM UNSATURATED IRON BINDING CAPACITY DURING IRON CHELATION THERAPY FOR IRON OVERLOAD
HFE POLYMORPHISMS AFFECT CHOLESTEROL AND SPHINGOLIPID METABOLISM
IRON INDUCED HEPATOMEGALY STUDY IN PATIENTS WITH IRON OVERLOAD AND IN IRON LOADED RATS
THE FERROPORTIN DISEASE REVISITED: A FRENCH COHORT OF 79 PATIENTS
HYPERFERRITINEMIA IN NONALCOHOLIC FATTY LIVER DISEASE: THE EFFECTS OF OBESITY-RELATED CHRONIC INFLAMMATION AND INCREASED BODY IRON STORES
OXIDATIVE STRESS, INDUCTION OF PROFIBROGENIC CYTOKINES AND ACCELERATED CCL4-INDUCED LIVER FIBROSIS IN A MOUSE MODEL OF HEMOCHROMATOSIS
IRON-DEPLETION AND REGULATION OF THE CELL CYCLE: IDENTIFICATION OF NF-γ IN THE TRANSCRIPTIONAL UP-REGULATION OF GROWTH ARREST AND DNA-DAMAGE-45α GENE (GADD45α)
INTERACTION BETWEEN THE PNPLA3 1148M MUTATION, BODY WEIGHT, AND STEATOSIS IN DETERMINING PROGRESSION TO CIRRHOSIS IN HEREDITARY HEMOCHROMATOSIS
THE RELATIONSHIP BETWEEN OBESITY, METABOLIC SYNDROME AND IRON DEFICIENCY IN NAFLD
ANALYSIS OF ABNORMAL IRON METABOLISM IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS
DUODENAL EXPRESSION OF IRON TRANSPORT-RELATED MOLECULES IN PATIENTS WITH CHRONIC LIVER DISEASE
ELEVATED SERUM FERRITIN VALUES ABOVE THE UPPER LIMIT OF NORMAL ARE ASSOCIATED WITH LABORATORY AND HISTOLOGIC EVIDENCE OF INCREASED NASH SEVERITY, BUT NOT THE PRESENCE OF DIABETES OR METABOLIC SYNDROME AMONG PATIENTS IN THE NASH CRN
NITROGEN MONOXIDE INHIBITS HEME SYNTHESIS IN MOUSE RETICULOCYTES
5-AZA-2′-DEOXYCYTIDINE ACTIVATES IRON UPTAKE AND HEME BIOSYNTHESIS VIA INCREASING C-MYC NUCLEAR LOCALIZATION AND BINDING TO THE E-BOX OF TFR1
EFFECTS OF ERYTHROPOIETIN ON HEPCIDIN-DEPENDENT REGULATION OF IRON HOMEOSTASIS
TRANSCRIPTIONAL REGULATION OF TRANSFERRIN RECEPTOR BY HEME IN ERYTHROID CELLS
ERYTHROPOIETIN-DRIVEN SIGNALING COMPLEMENTS THE SURVIVAL DEFECT OF DMT1-MUTANT ERYTHROID PROGENITORS
EXOGENOUS APO-TRANSFERRIN REDUCES EXTRAMEDULLARY AND INCREASES EFFECTIVENESS OF ERYTHROPOIESIS IN A MOUSE MODEL OF BETA-THALASSEMIA MAJOR
INDUCTION OF IRON DEFICIENCY ANEMIA IN RATS BY SHORT TIME ADMINISTRATION OF AN IRON DEFICIENT DIET AND EFFECTS ON LIVER PEROXIDES
TWO MOUSE MODELS ILLUSTRATE DIFFERENT MECHANISMS OF ANEMIA OF CANCER
HEPCIDIN IN ANEMIA OF AGING
CELIAC DISEASE: A CONDITION ASSOCIATED WITH IRON DEFICIENCY IN CAUCASIANS BUT NOT IN NON-CAUCASIANS IN THE HEMOCHROMATOSIS AND IRON OVERLOAD SCREENING (HEIRS) STUDY
MELANOTRANSFERRIN AND CELL CYCLE PROGRESSION
INDUCIBLE COMBINED IRP1/2 ABLATION IN ADULT MICE DEFINES IRP-DEPENDENT ASPECTS IN INTESTINAL IRON METABOLISM
FERROPORTIN EXPRESSION AND LOCALIZATION IN DIFFERENT GENETIC MOUSE MODELS OF HEMOCHROMATOSIS
MECHANISM OF IRON DEFICIENCY IN RATS AFTER RYGB SURGERY
BMP-6 LINKS THE LIVER AND DUODENUM IN IRON-LOADED HFE HEREDITARY HAEMOCHROMATOSIS
DIMINISHED FERROPORTIN1 PROTEIN EXPRESSION EXPLAINS THE HYPORESPONSIVENESS OF SUCKLING RATS TO STIMULI THAT REDUCE INTESTINAL IRON ABSORPTION
HIGH FAT DIET LEADS TO IRON DEFICIENCY DUE TO HEPCIDIN INDEPENDENT REDUCTION OF DUODENAL IRON ABSORPTION IN A MURINE ANIMAL MODEL OF OBESITY
TEMPORAL AND TISSUE-SPECIFIC ANALYSIS OF IRON LOADING IN MOUSE MODELS OF HEREDITARY HAEMOCHROMATOSIS
TRANSGENIC MICE HYPER-EXPRESSING MELANOTRANSFERRIN EXHIBIT A MILD HEMATOLOGICAL PHENOTYPE
IRON ABSORPTION IN HEPCIDIN1 KNOCKOUT MICE
THE ROLE OF IRON IN ATHEROSCLEROSIS: APPLICATION OF NEW IRON BIOLOGY
FERRITIN/FERROXIDASE ACTIVITY: A POTENT INHIBITOR OF VASCULAR SMOOTH MUSCLE CELL CALCIFICATION AND OSTEOGENESIS
IRON METABOLISM IN PATIENTS WITH MULTIFOCAL STENOSING ATHEROSCLEROSIS
IS HFE A POTENTIAL TARGET FOR CANCER?
ROLE OF IRON IN ASBESTOS-INDUCED MESOTHELIAL CARCINOGENESIS AND ITS PREVENTION STRATEGY
THE MINOR/HETERO ALLELE OF THE SNP IN MUTYH IS A SIGNIFICANT RISK FACTOR OF HEPATOCARCINOGENESIS FROM CHRONIC HEPATITIS C
FERRITIN BLOCKS INHIBITORY EFFECTS OF HKA ON ADHESION AND SURVIVAL SIGNALING IN ENDOTHELIAL CELLS
FERRITIN BINDS BREAST CANCER CELLS AND TISSUE, AND PROMOTES PROLIFERATION INDEPENDENTLY OF IRON CONTENT
MELANOTRANSFERRIN: A ROLE IN MELANOMA CELL PROLIFERATION AND TUMORIGENESIS
A NEW STRATEGY FOR THE TREATMENT OF PANCREATIC CANCER: NOVEL THIOSEMICARBAZONE IRON CHELATORS THAT UP-REGULATE THE IRON-REGULATED METASTASIS SUPPRESSOR, NDRG1
THE ANTI-TUMOR EFFECTS OF POTENTIAL IRON CELATORS FROM VACCINIUM MACROCARPON (CRANBERRIES) IN B16-F10 MELANOMA CELLS IN VITRO
DIETARY IRON PROMOTES INTESTINAL INFLAMMATION AND CARCINOGENESIS
EFFECT OF CONTROLLED REDUCTION OF BODY IRON STORES ON CLINICAL OUTCOMES IN PERIPHERAL ARTERIAL DISEASE (PAD)
IRON REGULATORY PROTEIN 2 REGULATES PANCREATIC BETA CELL MASS AND FUNCTION IN MICE
OCCURRENCE OF NON-HEPATIC TUMOURS IN SUBJECTS HOMOZYGOUS FOR C282Y HAEMOCHROMATOSIS
FERRITIN HEAVY CHAIN BINDS TO AND ACTIVATES THE HUMAN FETAL GLOBIN GENE AS WELL AS BINDS TO AND REPRESSES THE ADULT BETA GLOBIN GENE, OFFERING POTENTIAL THERAPIES FOR MALARIA AS WELL AS BETA-THALASSEMIA AND SICKLE CELL DISEASE
IN VIVO TESTING IN MOUSE MODELS USING FERRITIN HEAVY CHAIN AND ABSCISSIC ACID AS POTENTIAL THERAPIES FOR MALARIA, SICKLE CELL DISEASE AND BETA THALASSEMIAS
POTENTIAL THERAPEUTIC APPLICATIONS OF JAK2 INHIBITORS IN BETA-THALASSEMIA
HIGH THROUGHPUT SCREEN IDENTIFIES TWO CLASSES OF SMALL MOLECULES AS HEPCIDIN ANTAGONISTS
HEAVY CHAIN FERRITIN SIRNA DELIVERED BY CATIONIC LIPOSOMES INCREASES SENSITIVITIY OF CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS
DESIGN OF 3-HYDROXY-4-PYRIDINONE HEXADENTATE IRON CHELATORS WITH POTENTIAL ANTIMYCOBACTERIAL ACTIVITY
ZYGOSID - A SELECTIVE IRON CHELATOR ATTENUATES THE INFLAMMATORY PROCESSES IN A MOUSE MODEL OF ASTHMA
BLOCK OF HDMT1 BY XEN601, A SMALL MOLECULE USEFUL FOR TREATING IRON OVERLOAD DISORDERS
QUERCETIN INHIBITS FERROPORTIN EXPRESSION IN HUMAN INTESTINAL CACO-2 CELLS
HEPARIN IS A POTENT INHIBITOR OF HEPCIDIN EXPRESSION IN VITRO, IN MICE AND IN PATIENTS
LIVER-SPECIFIC DISRUPTION OF MOUSE HEMOJUVELIN RESULTS IN HEMOCHROMATOSIS
HEPATIC TRANSCRIPTIONAL ANALYSIS OF TFR2 GENE IN IRON OVERLOAD AND IRON DEFICIENCY CONDITION
HFE, TFR2 AND HJV ARE INTEGRAL PARTS OF A MULTI-PROTEIN COMPLEX
FOETAL IRON LEVELS ARE DETERMNIED BY MATERNAL HFE STATUS, DIETARY IRON LEVELS AND FOETAL LIVER HEPCIDIN EXPRESSION
WITHDRAWN
PREDICTION FOR RESIDUAL CONTACT PAIRS BETWEEN TRANSFERRIN AND TRANSFERRIN RECEPTOR 2 BY COMPUTATIONAL STRUCTURE MODELING
TESTOSTERONE INHIBITS HEPCIDIN EXPRESSION AND LEADS TO SEVERE IRON ACCUMULATION IN PANCREAS, HEART AND KIDNEY OF BMP6-DEFICIENT MICE
GATA-4 TRANSCRIPTION FACTOR REGULATES HEPCIDIN EXPRESSION IN A HUMAN HEPATIC CELL LINE
THE FRIEND OF GATA (FOG) -1 AND 2 REPRESSES THE GATA-DEPENDENT ACTIVATION OF HEPCIDIN IN HEPATOCYTES
EVIDENCE FOR DISTINCT PATHWAYS OF HEPCIDIN REGULATION BY ACUTE AND CHRONIC IRON LOADING
HYPOXIA MEDIATED DOWN-REGUALTION OF HEPCIDIN IS MEDIATED BY A TISSUE GROWTH FACTOR
NON-TRANSFERRIN-BOUND IRON DECREASES HEPCIDIN EXPRESSION IN VIVO AND ATTENUATES BMP/SMAD SIGNALING TO HEPCIDIN IN CULTURED HEPATOMA CELLS
EFFECT OF FERRITIN H OVEREXPRESSION ON RENAL ISCHEMIA REPERFUSION INJURY IN THE MOUSE
ITRAQ-BASED COMPARATIVE PROTEOMICS REVEALS CHANGE IN MACROPHAGE RAFT CONTAINING FERROPORTIN AFTER IRON TREATMENT
LONG-TERM EXPOSURE TO ETHANOL AFFECTS THE EXPRESSION OF MOLECULES INVOLVED IN NON-TRANSFERRIN IRON TRANSPORT IN CACO-2 CELLS
DESTABILIZATION OF IRON HOMEOSTASIS IN YEAST UPON ARSENIC EXPOSURE
SERUM FERROXIDASE ACTIVITY INCREASES IN IRON DEFICIENT RATS AND IS FURTHER ENHANCED BY HIGHER DIETARY COPPER INTAKE
WITHDRAWN